Search      
ABOUT US
Published Articles By PanC4 Members

Featured PanC4 Article
  • Bosetti C, Rosato V, Li D, et al. Diabetes, antidiabetic medications and pancreatic cancer risk: an analysis from the international pancreatic cancer case-control consortium. Ann Oncol. 2014 Jul 23.
  • Article Link

    Abstract from Bosetti et al Article

    • BACKGROUND: Type 2 diabetes mellitus has been associated with an excess risk of pancreatic cancer, but the magnitude of the risk and the time-risk relationship are unclear, and there is limited information on the role of antidiabetic medications.
    • PATIENTS AND METHODS: We analyzed individual-level data from 15 case-control studies within the Pancreatic Cancer Case-Control Consortium, including 8305 cases and 13,987 controls. Pooled odds ratios (ORs) were estimated from multiple logistic regression models, adjusted for relevant covariates.
    • RESULTS: Overall, 1155 (15%) cases and 1087 (8%) controls reported a diagnosis of diabetes two or more years before cancer diagnosis (or interview, for controls), corresponding to an odds ratio (OR) of 1.90 (95% confidence interval, CI, 1.72-2.09). Consistent risk estimates were observed across strata of selected covariates, including body mass index and tobacco smoking. Pancreatic cancer risk decreased with duration of diabetes, but a significant excess risk was still evident 20 or more years after diabetes diagnosis (OR 1.30 95% CI 1.17-2.03). Among diabetics, long duration of oral antidiabetic use was associated with a decreased pancreatic cancer risk (OR 0.31, 95% CI 0.14-0.69, for ≥15 years). Conversely, insulin use was associated with pancreatic cancer risk in the short-term (OR 5.60, 95% CI 3.75-8.35 for <5 years) but not for longer duration of use (OR 0.95, 95% CI 0.53-1.70, for ≥15 years).
    • CONCLUSION: This study provides the most definitive quantification to date of an excess risk of pancreatic cancer among diabetics. It also shows a 30% excess risk persists for more than two decades after diabetes diagnosis, thus supporting a causal role of diabetes in pancreatic cancer. Oral antidiabetics may decrease risk of pancreatic cancer risk, whereas insulin showed an inconsistent duration risk relationship.

        Commentary about Bosetti et al Article

  • Rahman A. Type 2 diabetes and risk of pancreatic adenocarcinoma. The Lancet Oncology. 2014.
  • Article Link


2014

  • Walker EJ, Ko AH, Holly EA, Bracci PM. Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study. Int J Cancer. 2014 Aug 4.
  • Boffetta P. Lack of association between occupational exposure to diesel exhaust and risk of pancreatic cancer: a systematic evaluation of available data. Int Arch Occup Environ Health. 2014 Jul;87(5):455-62.
  • Fehringer G, Gallinger S, Borgida A, et al. The association of family history of cancer and medical history with pancreatic cancer risk. Pancreas. 2014 Jul;43(5):812-4.
  • Streicher SA, Yu H, Lu L, Kidd MS, Risch HA. Case-control study of aspirin use and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1254-63.
  • Brenner DR, Wozniak MB, Feyt C, et al. Physical activity and risk of pancreatic cancer in a central European multicenter case-control study. Cancer Causes Control. 2014 Jun;25(6):669-81.
  • Wu L, Goldstein AM, Yu K, et al. Variants associated with susceptibility to pancreatic cancer and melanoma do not reciprocally affect risk. Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):1121-4.
  • Tang H, Wei P, Duell EJ, et al. Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS data. Carcinogenesis. 2014 May;35(5):1039-45.
  • Jansen RJ, Robinson DP, Frank RD, et al. Fatty acids found in dairy, protein and unsaturated fatty acids are associated with risk of pancreatic cancer in a case-control study. Int J Cancer. 2014 Apr 15;134(8):1935-46.
  • Xu HL, Cheng JR, Zhang W, et al. Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population. Chin J Cancer. 2014 Feb;33(2):68-73.
  • Pelucchi C, Galeone C, Polesel J, et al. Smoking and body mass index and survival in pancreatic cancer patients. Pancreas. 2014 Jan;43(1):47-52.
  • Risch HA, Lu L, Kidd MS, et al. Helicobacter pylori seropositivities and risk of pancreatic carcinoma. Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):172-8.
  • Tang H, Wei P, Duell EJ, et al. Genes-environment interactions in obesity- and diabetes-associated pancreatic cancer: a GWAS data analysis. Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):98-106.
  • Untawale S, Odegaard AO, Koh WP, Jin AZ, Yuan JM, Anderson KE. Body mass index and risk of pancreatic cancer in a Chinese population. PLoS One. 2014;9(1):e85149.
  • Yamada I, Matsuyama M, Ozaka M, et al. Lack of associations between genetic polymorphisms in GSTM1, GSTT1 and GSTP1 and pancreatic cancer risk: a multi-institutional case-control study in Japan. Asian Pac J Cancer Prev. 2014;15(1):391-5.
  • Willis JA, Mukherjee S, Orlow I, et al. Genome-wide analysis of the role of copy-number variation in pancreatic cancer risk. Front Genet. 2014;5:29.

2013

  • Tran B, Whiteman DC, Webb PM, et al. Association between ultraviolet radiation, skin sun sensitivity and risk of pancreatic cancer. Cancer Epidemiol. 2013 Dec;37(6):886-92.
  • Yu G, Murphy G, Michel A, et al. Seropositivity to Helicobacter pylori and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2416-9.
  • Bosetti C, Lucenteforte E, Bracci PM, et al. Ulcer, gastric surgery and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol. 2013 Nov;24(11):2903-10.
  • Jang JH, Cotterchio M, Borgida A, Liu G, Gallinger S, Cleary SP. Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk. Mol Carcinog. 2013 Nov;52 Suppl 1:E103-9.
  • Austin MA, Kuo E, Van Den Eeden SK, et al. Family history of diabetes and pancreatic cancer as risk factors for pancreatic cancer: the PACIFIC study. Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1913-7.
  • Jansen RJ, Robinson DP, Stolzenberg-Solomon RZ, et al. Polymorphisms in metabolism/antioxidant genes may mediate the effect of dietary intake on pancreatic cancer risk. Pancreas. 2013 Oct;42(7):1043-53.
  • Wang J, Zhang W, Sun L, et al. Dietary energy density is positively associated with risk of pancreatic cancer in urban Shanghai Chinese. J Nutr. 2013 Oct;143(10):1626-9.
  • Olson SH, Hsu M, Satagopan JM, et al. Allergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Am J Epidemiol. 2013 Sep 1;178(5):691-700.
  • Wolfgang CL, Herman JM, Laheru DA, et al. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013 Sep;63(5):318-48.
  • Jansen RJ, Robinson DP, Frank RD, et al. Meat-related mutagens and pancreatic cancer: null results from a clinic-based case-control study. Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1336-9.
  • Jansen RJ, Robinson DP, Stolzenberg-Solomon RZ, et al. Nutrients from fruit and vegetable consumption reduce the risk of pancreatic cancer. J Gastrointest Cancer. 2013 Jun;44(2):152-61.
  • Reid-Lombardo KM, Fridley BL, Bamlet WR, Cunningham JM, Sarr MG, Petersen GM. Survival is associated with genetic variation in inflammatory pathway genes among patients with resected and unresected pancreatic cancer. Ann Surg. 2013 Jun;257(6):1096-102.
  • Risch HA, Lu L, Wang J, et al. ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis. Am J Epidemiol. 2013 Jun 15;177(12):1326-37.
  • Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013 Jun;144(6):1252-61.
  • Huang L, Wu C, Yu D, et al. Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer. Carcinogenesis. 2013 May;34(5):1001-5.
  • Henry SA, Prizment AE, Anderson KE. Duration of diabetes and pancreatic cancer in a case-control study in the Midwest and the Iowa Womens Health Study (IWHS) cohort. Jop. 2013 May;14(3):243-9.
  • Bosetti C, Bravi F, Turati F, et al. Nutrient-based dietary patterns and pancreatic cancer risk. Ann Epidemiol. 2013 Mar;23(3):124-8.
  • Leenders M, Bhattacharjee S, Vineis P, et al. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Cancer Causes Control. 2013 Mar;24(3):595-602.
  • Parikh H, Jia J, Zhang X, et al. A resequence analysis of genomic loci on chromosomes 1q32.1, 5p15.33, and 13q22.1 associated with pancreatic cancer risk. Pancreas. 2013 Mar;42(2):209-15.
  • Olson SH, Kurtz RC. Epidemiology of pancreatic cancer and the role of family history. J Surg Oncol. 2013 Jan;107(1):1-7.
  • Chan JM, Gong Z, Holly EA, Bracci PM. Dietary patterns and risk of pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. Nutr Cancer. 2013;65(1):157-64.
  • Anderson LN, Cotterchio M, Knight JA, Borgida A, Gallinger S, Cleary SP. Genetic variants in vitamin d pathway genes and risk of pancreas cancer; results from a population-based case-control study in ontario, Canada. PLoS One. 2013;8(6):e66768.
  • Klein AP, Lindstrom S, Mendelsohn JB, et al. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. PLoS One. 2013;8(9):e72311.
  • Lin Y, Ueda J, Yagyu K, et al. Association between variations in the fat mass and obesity-associated gene and pancreatic cancer risk: a case-control study in Japan. BMC Cancer. 2013;13:337.
  • Mohamadkhani A, Naderi E, Sharafkhah M, Fazli HR, Moradzadeh M, Pourshams A. Detection of TP53 R249 Mutation in Iranian Patients with Pancreatic Cancer. J Oncol. 2013;2013:738915.

2012


    Table of Contents

    Introduction
    • Carcinogenesis of pancreatic cancer: Challenges, collaborations, progress (pages 1-2) Gloria M. Petersen and Paolo Boffetta
    Research Articles
    • Pancreatic cancer: Overview of descriptive epidemiology (pages 3-13) Cristina Bosetti, Paola Bertuccio, Eva Negri, Carlo La Vecchia, Maurice P. Zeegers and Paolo Boffetta
    In Perspective
    • Genetic susceptibility to pancreatic cancer (pages 14-24) Alison P. Klein
    • Aberrant signaling pathways in pancreatic cancer: A two compartment view (pages 25-39) Angela L. McCleary-Wheeler, Robert McWilliams and Martin E. Fernandez-Zapico
    In Perspectives
    • Epidemiology and potential mechanisms of tobacco smoking and heavy alcohol consumption in pancreatic cancer (pages 40-52) Eric J. Duell
    • Obesity and pancreatic cancer: Overview of epidemiologic evidence and biologic mechanisms (pages 53-63) Paige M. Bracci
    • Diabetes and pancreatic cancer (pages 64-74) Donghui Li
    Research Articles
    • Selected medical conditions and risk of pancreatic cancer (pages 75-97) Sara H. Olson
    • Occupational risk factors and pancreatic cancer: A review of recent findings (pages 98-108) Gabriella Andreotti and Debra T. Silverman
    • Pancreatic cancer: Helicobacter pylori colonization, N-Nitrosamine exposures, and ABO blood group (pages 109-118) Harvey A. Risch
    Working Hypothesis
    • Is dietary fat, vitamin D, or folate associated with pancreatic cancer? (pages 119-127) G.V. Sanchez, S.J. Weinstein and R.Z. Stolzenberg-Solomon
    Research Articles
    • Pancreatic cancer risk: Associations with meat-derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort (pages 128-137) Kristin E. Anderson, Steven J. Mongin, Rashmi Sinha, Rachael Stolzenberg-Solomon, Myron D. Gross, Regina G. Ziegler, Jerome E. Mabie, Adam Risch, Sally S. Kazin and Timothy R. Church
  • Gong Z, Holly EA, Bracci PM. Obesity and survival in population-based patients with pancreatic cancer in the San Francisco Bay Area. Cancer Causes Control. 2012 Dec;23(12):1929-37.
  • Yeo TP, Lowenfels AB. Demographics and epidemiology of pancreatic cancer. Cancer J. 2012 Nov-Dec;18(6):477-84.
  • Amaral AF, Porta M, Silverman DT, et al. Pancreatic cancer risk and levels of trace elements. Gut. 2012 Nov;61(11):1583-8.
  • Skinner HG, Gangnon RE, Litzelman K, et al. Telomere length and pancreatic cancer: a case-control study. Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2095-100.
  • Porta M, Pumarega J, Guarner L, Malats N, Sola R, Real FX. Relationships of hepatic and pancreatic biomarkers with the cholestatic syndrome and tumor stage in pancreatic cancer. Biomarkers. 2012 Sep;17(6):557-65.
  • Wang J, Zhang W, Sun L, Yu H, Ni QX, Risch HA, Gao YT. Green tea drinking and risk of pancreatic cancer: A large-scale, population-based case-control study in urban Shanghai. Cancer Epidemiol. 2012 Aug 31. [Epub ahead of print] PubMed PMID: 22944495.
  • Nakao M, Hosono S, Ito H, Watanabe M, Mizuno N, Sato S, Yatabe Y, Yamao K, Ueda R, Tajima K, Tanaka H, Matsuo K. Selected Polymorphisms of Base Excision Repair Genes and Pancreatic Cancer Risk in Japanese. J Epidemiol. 2012 Jul 28. [Epub ahead of print] PubMed PMID: 22850545.
  • Willis JA, Olson SH, Orlow I, et al. A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival. Clin Cancer Res. 2012 Jul 15;18(14):3942-51.
  • Duell EJ, Lucenteforte E, Olson SH, Bracci PM, Li D, Risch HA, Silverman DT, Ji BT, Gallinger S, Holly EA, Fontham EH, Maisonneuve P, Bueno-de-Mesquita HB, Ghadirian P, Kurtz RC, Ludwig E, Yu H, Lowenfels AB, Seminara D, Petersen GM, La Vecchia C, Boffetta P. Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol. 2012 Jul 5. [Epub ahead of print] PubMed PMID: 22767586.
  • Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji BT, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Bertuccio P, Gao YT, Hassan M, Yu H, Kurtz RC, Cotterchio M, Su J, Maisonneuve P, Duell EJ, Boffetta P, La Vecchia C. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol. 2012 Jul;23(7):1880-8. Epub 2011 Nov 21. PubMed PMID: 22104574; PubMed Central PMCID: PMC3387822.
  • Li D, Duell EJ, Yu K, Risch HA, Olson SH, Kooperberg C, Wolpin BM, Jiao L, Dong X, Wheeler B, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, Hartge P, Hoover RN, Holly EA, Jacobs EJ, Klein AP, Lacroix A, Mandelson MT, Petersen G, Zheng W, Agalliu I, Albanes D, Boutron-Ruault MC, Bracci PM, Buring JE, Canzian F, Chang K, Chanock SJ, Cotterchio M, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hankinson SE, Hoffman Bolton JA, Hunter DJ, Hutchinson A, Jacobs KB, Jenab M, Khaw KT, Kraft P, Krogh V, Kurtz RC, McWilliams RR, Mendelsohn JB, Patel AV, Rabe KG, Riboli E, Shu XO, Tjønneland A, Tobias GS, Trichopoulos D, Virtamo J, Visvanathan K, Watters J, Yu H, Zeleniuch-Jacquotte A, Amundadottir L, Stolzenberg-Solomon RZ. Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis. 2012 Jul;33(7):1384-90. Epub 2012 Apr 20. PubMed PMID: 22523087; PubMed Central PMCID: PMC3405651.
  • He S, Zhao H, Fei M, Wu Y, Wang L, Zhu X, Li D. Expression of the co-signaling molecules CD40-CD40L and their growth inhibitory effect on pancreatic cancer in vitro. Oncol Rep. 2012 Jul;28(1):262-8. doi: 10.3892/or.2012.1790. Epub 2012 Apr 26. PubMed PMID: 22552529.
  • Rossi M, Lugo A, Lagiou P, Zucchetto A, Polesel J, Serraino D, Negri E, Trichopoulos D, La Vecchia C. Proanthocyanidins and other flavonoids in relation to pancreatic cancer: a case-control study in Italy. Ann Oncol. 2012 Jun;23(6):1488-93. Epub 2011 Nov 2. PubMed PMID: 22052986.
  • Dong X, Li Y, Chang P, Hess KR, Abbruzzese JL, Li D. DNA mismatch repair network gene polymorphism as a susceptibility factor for pancreatic cancer. Mol Carcinog. 2012 Jun;51(6):491-9.
  • Bracci PM, Zhou M, Young S, Wiemels J. Serum autoantibodies to pancreatic cancer antigens as biomarkers of pancreatic cancer in a San Francisco Bay Area case-control study. Cancer. 2012 Apr 19. doi: 10.1002/cncr.27538. [Epub ahead of print] PubMed PMID: 22517435; PubMed Central PMCID: PMC3414682.
  • Chang DZ, Ma Y, Ji B, Liu Y, Hwu P, Abbruzzese JL, Logsdon C, Wang H. Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression. J Hematol Oncol. 2012 Apr 4;5:15. PubMed PMID: 22475564; PubMed Central PMCID: PMC3350393.
  • Dong X, Li Y, Tang H, et al. Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer. Cancer Epidemiol. 2012 Apr;36(2):206-11.
  • Jang JH, Cotterchio M, Borgida A, Gallinger S, Cleary SP. Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk. Carcinogenesis. 2012 Apr;33(4):818-27. Epub 2012 Feb 2. PubMed PMID: 22301281; PubMed Central PMCID: PMC3324443.
  • Lam ET, Bracci PM, Holly EA, et al. Mitochondrial DNA sequence variation and risk of pancreatic cancer. Cancer Res. 2012 Feb 1;72(3):686-95.
  • Lucenteforte E, La Vecchia C, Silverman D, et al. Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol. 2012 Feb;23(2):374-82.
  • Andreotti G, Silverman DT. Occupational risk factors and pancreatic cancer: a review of recent findings. Mol Carcinog. 2012 Jan;51(1):98-108.
  • Bosetti C, Bertuccio P, Negri E, La Vecchia C, Zeegers MP, Boffetta P. Pancreatic cancer: overview of descriptive epidemiology. Mol Carcinog. 2012 Jan;51(1):3-13.
  • Bracci PM. Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms. Mol Carcinog. 2012 Jan;51(1):53-63.
  • Duell EJ. Epidemiology and potential mechanisms of tobacco smoking and heavy alcohol consumption in pancreatic cancer. Mol Carcinog. 2012 Jan;51(1):40-52.
  • Huang L, Yu D, Wu C, et al. Copy number variation at 6q13 functions as a long-range regulator and is associated with pancreatic cancer risk. Carcinogenesis. 2012 Jan;33(1):94-100.
  • Li D. Diabetes and pancreatic cancer. Mol Carcinog. 2012 Jan;51(1):64-74.
  • Olson SH. Selected medical conditions and risk of pancreatic cancer. Mol Carcinog. 2012 Jan;51(1):75-97.
  • Petersen GM, Boffetta P. Carcinogenesis of pancreatic cancer: challenges, collaborations, progress. Mol Carcinog. 2012 Jan;51(1):1-2.
  • Prizment AE, Gross M, Rasmussen-Torvik L, Peacock JM, Anderson KE. Genes related to diabetes may be associated with pancreatic cancer in a population-based case-control study in Minnesota. Pancreas. 2012 Jan;41(1):50-3.
  • Risch HA. Pancreatic cancer: Helicobacter pylori colonization, N-nitrosamine exposures, and ABO blood group. Mol Carcinog. 2012 Jan;51(1):109-18.
  • Luckett BG, Su LJ, Rood JC, Fontham ET. Cadmium exposure and pancreatic cancer in south Louisiana. J Environ Public Health. 2012;2012:180186.
  • Wei P, Tang H, Li D. Insights into pancreatic cancer etiology from pathway analysis of genome-wide association study data. PLoS One. 2012;7(10):e46887.

2011

  • Kisiel JB, Yab TC, Taylor WR, Chari ST, Petersen GM, Mahoney DW, Ahlquist DA. Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates. Cancer. 2012 May 15;118(10):2623-31. doi: 10.1002/cncr.26558. Epub 2011 Sep 22. PubMed PMID: 22083596; PubMed Central PMCID: PMC3292683.
  • Turati F, Galeone C, Edefonti V, Ferraroni M, Lagiou P, La Vecchia C, Tavani A. A meta-analysis of coffee consumption and pancreatic cancer. Ann Oncol. 2012 Feb;23(2):311-8. Epub 2011 Jul 11. PubMed PMID: 21746805.
  • Lucenteforte E, La Vecchia C, Silverman D, Petersen GM, Bracci PM, Ji BT, Bosetti C, Li D, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Gao YT, Negri E, Hassan M, Cotterchio M, Su J, Maisonneuve P, Boffetta P, Duell EJ. Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol. 2012 Feb;23(2):374-82. Epub 2011 May 2. PubMed PMID: 21536662; PubMed Central PMCID: PMC3265544.
  • Lam ET, Bracci PM, Holly EA, Chu C, Poon A, Wan E, White K, Kwok PY, Pawlikowska L, Tranah GJ. Mitochondrial DNA sequence variation and risk of pancreatic cancer. Cancer Res. 2012 Feb 1;72(3):686-95. Epub 2011 Dec 15. PubMed PMID: 22174369; PubMed Central PMCID: PMC3271167.
  • Bidoli E, Pelucchi C, Zucchetto A, Negri E, Dal Maso L, Polesel J, Boz G, Montella M, Franceschi S, Serraino D, La Vecchia C, Talamini R. Fiber intake and pancreatic cancer risk: a case-control study. Ann Oncol. 2012 Jan;23(1):264-8. Epub 2011 Apr 2. PubMed PMID: 21460379.
  • Prizment AE, Gross M, Rasmussen-Torvik L, Peacock JM, Anderson KE. Genes related to diabetes may be associated with pancreatic cancer in a population-based case-control study in Minnesota. Pancreas. 2012 Jan;41(1):50-3. PubMed PMID: 22015968; PubMed Central PMCID: PMC3241825.
  • Urayama KY, Holcatova I, Janout V, Foretova L, Fabianova E, Adamcakova Z, Ryska M, Martinek A, Shonova O, Brennan P, Scélo G. Body mass index and body size in early adulthood and risk of pancreatic cancer in a central European multicenter case-control study. Int J Cancer. 2011 Dec 15;129(12):2875-84. doi: 10.1002/ijc.25959. Epub 2011 Apr 25. PubMed PMID: 21520034; PubMed Central PMCID: PMC3146968.
  • Wu C, Miao X, Huang L, Che X, Jiang G, Yu D, Yang X, Cao G, Hu Z, Zhou Y, Zuo C, Wang C, Zhang X, Zhou Y, Yu X, Dai W, Li Z, Shen H, Liu L, Chen Y, Zhang S, Wang X, Zhai K, Chang J, Liu Y, Sun M, Cao W, Gao J, Ma Y, Zheng X, Cheung ST, Jia Y, Xu J, Tan W, Zhao P, Wu T, Wang C, Lin D. Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nat Genet. 2011 Dec 11;44(1):62-6. doi: 10.1038/ng.1020. PubMed PMID: 22158540.
  • Jansen RJ, Robinson DP, Stolzenberg-Solomon RZ, Bamlet WR, de Andrade M, Oberg AL, Hammer TJ, Rabe KG, Anderson KE, Olson JE, Sinha R, Petersen GM. Fruit and vegetable consumption is inversely associated with having pancreatic cancer. Cancer Causes Control. 2011 Dec;22(12):1613-25. Epub 2011 Sep 14. PubMed PMID: 21915615.
  • Tan XL, Reid Lombardo KM, Bamlet WR, Oberg AL, Robinson DP, Anderson KE, Petersen GM. Aspirin, nonsteroidal anti-inflammatory drugs, acetaminophen, and pancreatic cancer risk: a clinic-based case-control study. Cancer Prev Res (Phila). 2011 Nov;4(11):1835-41. Epub 2011 Jul 29. PubMed PMID: 21803981; PubMed Central PMCID: PMC3208748.
  • Rosato V, Tavani A, Bosetti C, Pelucchi C, Talamini R, Polesel J, Serraino D, Negri E, La Vecchia C. Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and meta-analysis. Metabolism. 2011 Oct;60(10):1372-8. Epub 2011 May 6. PubMed PMID: 21550085.
  • Pelucchi C, Galeone C, Talamini R, Negri E, Polesel J, Serraino D, La Vecchia C. Dietary acrylamide and pancreatic cancer risk in an Italian case--control study. Ann Oncol. 2011 Aug;22(8):1910-5. Epub 2011 Feb 1. PubMed PMID: 21285136.
  • Matsubayashi H, Maeda A, Kanemoto H, Uesaka K, Yamazaki K, Hironaka S, Miyagi Y, Ikehara H, Ono H, Klein A, Goggins M. Risk factors of familial pancreatic cancer in Japan: current smoking and recent onset of diabetes. Pancreas. 2011 Aug;40(6):974-8. PubMed PMID: 21487321.
  • Pelucchi C, La Vecchia C, Bosetti C, Boyle P, Boffetta P. Exposure to acrylamide and human cancer--a review and meta-analysis of epidemiologic studies. Ann Oncol. 2011 Jul;22(7):1487-99. Epub 2011 Jan 13. Review. PubMed PMID: 21239401.
  • Turati F, Galeone C, Talamini R, Franceschi S, Manzari M, Gallino G, Polesel J, La Vecchia C, Tavani A. Coffee, decaffeinated coffee, tea, and pancreatic cancer risk: a pooled-analysis of two Italian case-control studies. Eur J Cancer Prev. 2011 Jul;20(4):287-92. PubMed PMID: 21403521.
  • Parker LA, Lumbreras B, Lopez T, Hernández-Aguado I, Porta M. How useful is it clinically to analyse the K-ras mutational status for the diagnosis of exocrine pancreatic cancer? A systematic review and meta-analysis. Eur J Clin Invest. 2011 Jul;41(7):793-805. doi: 10.1111/j.1365-2362.2011.02495.x. Epub 2011 Mar 9. Review. PubMed PMID: 21391995.
  • Zeng H, Yu H, Lu L, Jain D, Kidd MS, Saif MW, Chanock SJ, Hartge P; PanScan Consortium, Risch HA. Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer. Pancreas. 2011 Jul;40(5):657-63. PubMed PMID: 21487324; PubMed Central PMCID: PMC3116071.
  • Bertuccio P, La Vecchia C, Silverman DT, Petersen GM, Bracci PM, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham ET, Bamlet WR, Holly EA, Lucenteforte E, Hassan M, Yu H, Kurtz RC, Cotterchio M, Su J, Maisonneuve P, Duell EJ, Bosetti C, Boffetta P. Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol. 2011 Jun;22(6):1420-6. Epub 2011 Jan 18. PubMed PMID: 21245160; PubMed Central PMCID: PMC3139985.
  • Reid-Lombardo KM, Fridley BL, Bamlet WR, Cunningham JM, Sarr MG, Petersen GM. Inflammation-related gene variants as risk factors for pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1251-4. Epub 2011 Apr 5. PubMed PMID: 21467233; PubMed Central PMCID: PMC3111756.
  • Tang H, Dong X, Hassan M, Abbruzzese JL, Li D. Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):779-92. Epub 2011 Feb 25. PubMed PMID: 21357378; PubMed Central PMCID: PMC3089680.
  • Nakao M, Matsuo K, Hosono S, Ogata S, Ito H, Watanabe M, Mizuno N, Iida S, Sato S, Yatabe Y, Yamao K, Ueda R, Tajima K, Tanaka H. ABO blood group alleles and the risk of pancreatic cancer in a Japanese population. Cancer Sci. 2011 May;102(5):1076-80. doi: 10.1111/j.1349-7006.2011.01907.x. Epub 2011 Mar 14. PubMed PMID: 21306478.
  • Pelucchi C, Zucchetto A, Tavani A, Dal Maso L, Serraino D, La Vecchia C. Physical activity and pancreatic cancer risk. Int J Cancer. 2011 May 1;128(9):2243-5. doi: 10.1002/ijc.25548. PubMed PMID: 20617512.
  • Tranah GJ, Holly EA, Wang F, Bracci PM. Cigarette, cigar and pipe smoking, passive smoke exposure, and risk of pancreatic cancer: a population-based study in the San Francisco Bay Area. BMC Cancer. 2011 Apr 15;11:138. PubMed PMID: 21496267; PubMed Central PMCID: PMC3094325.
  • Lucenteforte E, Zucchetto A, Bosetti C, Talamini R, Negri E, Serraino D, Franceschi S, Lipworth L, La Vecchia C. Reproductive and hormonal factors and pancreatic cancer risk in women. Pancreas. 2011 Apr;40(3):460-3. PubMed PMID: 21343831.
  • Lipworth L, Zucchetto A, Bosetti C, Franceschi S, Talamini R, Serraino D, McLaughlin JK, La Vecchia C, Negri E. Diabetes mellitus, other medical conditions and pancreatic cancer: a case-control study. Diabetes Metab Res Rev. 2011 Mar;27(3):255-61. doi: 10.1002/dmrr.1162. PubMed PMID: 21309046.
  • Li D, Tang H, Hassan MM, Holly EA, Bracci PM, Silverman DT. Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control. 2011 Feb;22(2):189-97. Epub 2010 Nov 21. PubMed PMID: 21104117.
  • Bravi F, Polesel J, Bosetti C, Talamini R, Negri E, Dal Maso L, Serraino D, La Vecchia C. Dietary intake of selected micronutrients and the risk of pancreatic cancer: an Italian case-control study. Ann Oncol. 2011 Jan;22(1):202-6. Epub 2010 Jun 7. PubMed PMID: 20530201.
  • Zablotska LB, Gong Z, Wang F, Holly EA, Bracci PM. Vitamin D, calcium, and retinol intake, and pancreatic cancer in a population-based case-control study in the San Francisco Bay area. Cancer Causes Control. 2011 Jan;22(1):91-100. Epub 2010 Nov 12. PubMed PMID: 21072578; PubMed Central PMCID: PMC3002162.
  • Gallus S, Turati F, Tavani A, Polesel J, Talamini R, Franceschi S, La Vecchia C. Soft drinks, sweetened beverages and risk of pancreatic cancer. Cancer Causes Control. 2011 Jan;22(1):33-9. Epub 2010 Oct 28. PubMed PMID: 20981481.
  • Dong X, Li Y, Hess KR, Abbruzzese JL, Li D. DNA mismatch repair gene polymorphisms affect survival in pancreatic cancer. Oncologist. 2011;16(1):61-70. Epub 2011 Jan 6. PubMed PMID: 21212431; PubMed Central PMCID: PMC3228057.
  • Mohelnikova-Duchonova B, Marsakova L, Vrana D, Holcatova I, Ryska M, Smerhovsky Z, Slamova A, Schejbalova M, Soucek P. Superoxide dismutase and nicotinamide adenine dinucleotide phosphate: quinone oxidoreductase polymorphisms and pancreatic cancer risk. Pancreas. 2011 Jan;40(1):72-8. PubMed PMID: 20966810.

2010

  • Iodice S, Maisonneuve P, Botteri E, Sandri MT, Lowenfels AB. ABO blood group and cancer. Eur J Cancer. 2010 Dec;46(18):3345-50. Review. PubMed PMID: 20833034.
  • Olson SH, Chou JF, Ludwig E, O'Reilly E, Allen PJ, Jarnagin WR, Bayuga S, Simon J, Gonen M, Reisacher WR, Kurtz RC. Allergies, obesity, other risk factors and survival from pancreatic cancer. Int J Cancer. 2010 Nov 15;127(10):2412-9. PubMed PMID: 20143395.
  • Gong Z, Holly EA, Wang F, Chan JM, Bracci PM. Intake of fatty acids and antioxidants and pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. Int J Cancer. 2010 Oct 15;127(8):1893-904. PubMed PMID: 20104522; PubMed Central PMCID: PMC2930138.
  • Santibañez M, Vioque J, Alguacil J, de la Hera MG, Moreno-Osset E, Carrato A, Porta M, Kauppinen T. Occupational exposures and risk of pancreatic cancer. Eur J Epidemiol. 2010 Oct;25(10):721-30. Epub 2010 Jul 17. PubMed PMID: 20640489.
  • Bonifazi M, Gallus S, Bosetti C, Polesel J, Serraino D, Talamini R, Negri E, La Vecchia C. Aspirin use and pancreatic cancer risk. Eur J Cancer Prev. 2010 Sep;19(5):352-4. PubMed PMID: 20502343.
  • Fong PY, Fesinmeyer MD, White E, Farin FM, Srinouanprachanh S, Afsharinejad Z, Mandelson MT, Brentnall TA, Barnett MJ, Goodman GE, Austin MA. Association of diabetes susceptibility gene calpain-10 with pancreatic cancer among smokers. J Gastrointest Cancer. 2010 Sep;41(3):203-8. PubMed PMID: 20178008; PubMed Central PMCID: PMC2952047.
  • Dong X, Javle M, Hess KR, Shroff R, Abbruzzese JL, Li D. Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer. Gastroenterology. 2010 Aug;139(2):464-73, 473.e1-3. Epub 2010 Apr 21. PubMed PMID: 20416304; PubMed Central PMCID: PMC2910789.
  • Gupta S, Wang F, Holly EA, Bracci PM. Risk of pancreatic cancer by alcohol dose, duration, and pattern of consumption, including binge drinking: a population-based study. Cancer Causes Control. 2010 Jul;21(7):1047-59. Epub 2010 Mar 27. PubMed PMID: 20349126; PubMed Central PMCID: PMC2883092.
  • Li A, Omura N, Hong SM, Vincent A, Walter K, Griffith M, Borges M, Goggins M. Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. Cancer Res. 2010 Jul 1;70(13):5226-37. Epub 2010 Jun 15. PubMed PMID: 20551052; PubMed Central PMCID: PMC3130565.
  • Meinhold CL, Dodd KW, Jiao L, Flood A, Shikany JM, Genkinger JM, Hayes RB, Stolzenberg-Solomon RZ. Available carbohydrates, glycemic load, and pancreatic cancer: is there a link? Am J Epidemiol. 2010 Jun 1;171(11):1174-82. Epub 2010 May 7. PubMed PMID: 20452999; PubMed Central PMCID: PMC2915491.
  • Rossi M, Lipworth L, Polesel J, Negri E, Bosetti C, Talamini R, McLaughlin JK, La Vecchia C. Dietary glycemic index and glycemic load and risk of pancreatic cancer: a case-control study. Ann Epidemiol. 2010 Jun;20(6):460-5. PubMed PMID: 20470973.
  • Ghadirian P, Nkondjock A. Consumption of food groups and the risk of pancreatic cancer: a case-control study. J Gastrointest Cancer. 2010 Jun;41(2):121-9. PubMed PMID: 20101477.
  • Zhan YS, Feng L, Tang SH, Li WG, Xu M, Liu TF, Zhou YF, Ma YL, Zhang Y, Pu XM. Glucose metabolism disorders in cancer patients in a Chinese population. Med Oncol. 2010 Jun;27(2):177-84. Epub 2009 Mar 5. PubMed PMID: 19263254.
  • Risch HA, Yu H, Lu L, Kidd MS. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst. 2010 Apr 7;102(7):502-5. Epub 2010 Feb 24. PubMed PMID: 20181960; PubMed Central PMCID: PMC2902822.
  • Polesel J, Talamini R, Negri E, Bosetti C, Boz G, Lucenteforte E, Franceschi S, Serraino D, La Vecchia C. Dietary habits and risk of pancreatic cancer: an Italian case-control study. Cancer Causes Control. 2010 Apr;21(4):493-500. Epub 2009 Nov 29. PubMed PMID: 20091114.
  • Naccarati A, Pardini B, Polakova V, Smerhovsky Z, Vodickova L, Soucek P, Vrana D, Holcatova I, Ryska M, Vodicka P. Genotype and haplotype analysis of TP53 gene and the risk of pancreatic cancer: an association study in the Czech Republic. Carcinogenesis. 2010 Apr;31(4):666-70. Epub 2010 Jan 28. PubMed PMID: 20110284.
  • Tang H, Dong X, Day RS, Hassan MM, Li D. Antioxidant genes, diabetes and dietary antioxidants in association with risk of pancreatic cancer. Carcinogenesis. 2010 Apr;31(4):607-13. Epub 2010 Jan 22. PubMed PMID: 20097730; PubMed Central PMCID: PMC2847085.
  • Tramacere I, Scotti L, Jenab M, Bagnardi V, Bellocco R, Rota M, Corrao G, Bravi F, Boffetta P, La Vecchia C. Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation. Int J Cancer. 2010 Mar 15;126(6):1474-86. PubMed PMID: 19816941.
  • Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, Arslan AA, Bueno-de-Mesquita HB, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Klein AP, LaCroix A, Li D, Mandelson MT, Olson SH, Risch HA, Zheng W, Albanes D, Bamlet WR, Berg CD, Boutron-Ruault MC, Buring JE, Bracci PM, Canzian F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hankinson SE, Hassan M, Howard B, Hunter DJ, Hutchinson A, Jenab M, Kaaks R, Kooperberg C, Krogh V, Kurtz RC, Lynch SM, McWilliams RR, Mendelsohn JB, Michaud DS, Parikh H, Patel AV, Peeters PH, Rajkovic A, Riboli E, Rodriguez L, Seminara D, Shu XO, Thomas G, Tjønneland A, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wang Z, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Fraumeni JF Jr, Hoover RN, Hartge P, Chanock SJ. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet. 2010 Mar;42(3):224-8. Epub 2010 Jan 24. PubMed PMID: 20101243; PubMed Central PMCID: PMC2853179.
  • Mohelnikova-Duchonova B, Vrana D, Holcatova I, Ryska M, Smerhovsky Z, Soucek P. CYP2A13, ADH1B, and ADH1C gene polymorphisms and pancreatic cancer risk. Pancreas. 2010 Mar;39(2):144-8. PubMed PMID: 19812523.
  • Maisonneuve P, Lowenfels AB, Bueno-de-Mesquita HB, Ghadirian P, Baghurst PA, Zatonski WA, Miller AB, Duell EJ, Boffetta P, Boyle P. Past medical history and pancreatic cancer risk: Results from a multicenter case-control study. Ann Epidemiol. 2010 Feb;20(2):92-8. PubMed PMID: 20123159.
  • Lucenteforte E, Talamini R, Bosetti C, Polesel J, Franceschi S, Serraino D, Negri E, La Vecchia C. Macronutrients, fatty acids, cholesterol and pancreatic cancer. Eur J Cancer. 2010 Feb;46(3):581-7. Epub 2009 Oct 21. PubMed PMID: 19850469.
  • Duell EJ, Holly EA, Kelsey KT, Bracci PM. Genetic variation in CYP17A1 and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Int J Cancer. 2010 Feb 1;126(3):790-5. PubMed PMID: 19642097.
  • McWilliams RR, Petersen GM, Rabe KG, Holtegaard LM, Lynch PJ, Bishop MD, Highsmith WE Jr. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma. Cancer. 2010 Jan 1;116(1):203-9. PubMed PMID: 19885835; PubMed Central PMCID: PMC2807917.
  • Talamini R, Polesel J, Gallus S, Dal Maso L, Zucchetto A, Negri E, Bosetti C, Lucenteforte E, Boz G, Franceschi S, Serraino D, La Vecchia C. Tobacco smoking, alcohol consumption and pancreatic cancer risk: a case-control study in Italy. Eur J Cancer. 2010 Jan;46(2):370-6. Epub 2009 Sep 24. PubMed PMID: 19782561.
  • Takayama R, Nakagawa H, Sawaki A, Mizuno N, Kawai H, Tajika M, Yatabe Y, Matsuo K, Uehara R, Ono K, Nakamura Y, Yamao K. Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma. J Gastroenterol. 2010;45(1):52-9. Epub 2009 Sep 30. PubMed PMID: 19789838.
  • Vrana D, Novotny J, Holcatova I, Hlavata I, Soucek P. CYP1B1 gene polymorphism modifies pancreatic cancer risk but not survival. Neoplasma. 2010;57(1):15-9. PubMed PMID: 19895167.

2009

  • Bracci PM, Wang F, Hassan MM, Gupta S, Li D, Holly EA. Pancreatitis and pancreatic cancer in two large pooled case-control studies. Cancer Causes Control. 2009 Nov;20(9):1723-1731. PubMed PMID: 19760029; PubMed Central PMCID: PMC2767517.
  • Couch FJ, Wang X, McWilliams RR, Bamlet WR, de Andrade M, Petersen GM. Association of breast cancer susceptibility variants with risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3044-8. Epub 2009 Oct 20. PubMed PMID: 19843670; PubMed Central PMCID: PMC3248348.
  • Vrana D, Pikhart H, Mohelnikova-Duchonova B, Holcatova I, Strnad R, Slamova A, Schejbalova M, Ryska M, Susova S, Soucek P. The association between glutathione S-transferase gene polymorphisms and pancreatic cancer in a central European Slavonic population. Mutat Res. 2009 Nov-Dec;680(1-2):78-81. Epub 2009 Sep 26. PubMed PMID: 19786118.
  • Gong Z, Holly EA, Bracci PM. Intake of folate, vitamins B6, B12 and methionine and risk of pancreatic cancer in a large population-based case-control study. Cancer Causes Control. 2009 Oct;20(8):1317-25. Epub 2009 May 5. PubMed PMID: 19415507; PubMed Central PMCID: PMC3306816.
  • Pannala R, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M, Petersen GM, Chari ST. Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer. Am J Gastroenterol. 2009 Sep;104(9):2318-25. Epub 2009 Jun 9. PubMed PMID: 19513024; PubMed Central PMCID: PMC2779576.
  • Walter K, Hong SM, Nyhan S, Canto M, Fedarko N, Klein A, Griffith M, Omura N, Medghalchi S, Kuhajda F, Goggins M. Serum fatty acid synthase as a marker of pancreatic neoplasia. Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2380-5. Epub 2009 Sep 1. PubMed PMID: 19723916; PubMed Central PMCID: PMC2860720.
  • McWilliams RR, Bamlet WR, de Andrade M, Rider DN, Couch FJ, Cunningham JM, Matsumoto ME, Rabe KG, Hammer TJ, Petersen GM. Polymorphic variants in hereditary pancreatic cancer genes are not associated with pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2549-52. Epub 2009 Aug 18. PubMed PMID: 19690177; PubMed Central PMCID: PMC2742574.
  • Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Zheng W, Albanes D, Bamlet W, Berg CD, Berrino F, Bingham S, Buring JE, Bracci PM, Canzian F, Clavel-Chapelon F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Fox JW Jr, Gallinger S, Gaziano JM, Giovannucci EL, Goggins M, González CA, Hallmans G, Hankinson SE, Hassan M, Holly EA, Hunter DJ, Hutchinson A, Jackson R, Jacobs KB, Jenab M, Kaaks R, Klein AP, Kooperberg C, Kurtz RC, Li D, Lynch SM, Mandelson M, McWilliams RR, Mendelsohn JB, Michaud DS, Olson SH, Overvad K, Patel AV, Peeters PH, Rajkovic A, Riboli E, Risch HA, Shu XO, Thomas G, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Chanock SJ, Hartge P, Hoover RN. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009 Sep;41(9):986-90. Epub 2009 Aug 2. PubMed PMID: 19648918; PubMed Central PMCID: PMC2839871.
  • Chan JM, Wang F, Holly EA. Sweets, sweetened beverages, and risk of pancreatic cancer in a large population-based case-control study. Cancer Causes Control. 2009 Aug;20(6):835-46. Epub 2009 Mar 11. PubMed PMID: 19277880; PubMed Central PMCID: PMC2694313.
  • Anderson LN, Cotterchio M, Gallinger S. Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada. Cancer Causes Control. 2009 Aug;20(6):825-34. Epub 2009 Feb 5. PubMed PMID: 19194662.
  • Bosetti C, Gallus S, Talamini R, Montella M, Franceschi S, Negri E, La Vecchia C. Artificial sweeteners and the risk of gastric, pancreatic, and endometrial cancers in Italy. Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2235-8. PubMed PMID: 19661082.
  • Li D, Yeung SC, Hassan MM, Konopleva M, Abbruzzese JL. Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology. 2009 Aug;137(2):482-8. Epub 2009 Apr 16. PubMed PMID: 19375425; PubMed Central PMCID: PMC2735093.
  • Zaridze D, Brennan P, Boreham J, Boroda A, Karpov R, Lazarev A, Konobeevskaya I, Igitov V, Terechova T, Boffetta P, Peto R. Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48,557 adult deaths. Lancet. 2009 Jun 27;373(9682):2201-14. PubMed PMID: 19560602; PubMed Central PMCID: PMC2715218.
  • Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML, Abbruzzese JL. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA. 2009 Jun 24;301(24):2553-62. PubMed PMID: 19549972; PubMed Central PMCID: PMC2760963.
  • McWilliams RR, Bamlet WR, de Andrade M, Rider DN, Cunningham JM, Petersen GM. Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L. Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1295-302. Epub 2009 Mar 24. PubMed PMID: 19318433; PubMed Central PMCID: PMC2710767.
  • Chen J, Chen Z, Chen M, Li D, Li Z, Xiong Y, Dong J, Li X. Role of fibrillar Tenascin-C in metastatic pancreatic cancer. Int J Oncol. 2009 Apr;34(4):1029-36. PubMed PMID: 19287959.
  • Kanda J, Matsuo K, Suzuki T, Kawase T, Hiraki A, Watanabe M, Mizuno N, Sawaki A, Yamao K, Tajima K, Tanaka H. Impact of alcohol consumption with polymorphisms in alcohol-metabolizing enzymes on pancreatic cancer risk in Japanese. Cancer Sci. 2009 Feb;100(2):296-302. PubMed PMID: 19068087.
  • Zhang J, Dhakal IB, Gross MD, Lang NP, Kadlubar FF, Harnack LJ, Anderson KE. Physical activity, diet, and pancreatic cancer: a population-based, case-control study in Minnesota. Nutr Cancer. 2009;61(4):457-65. PubMed PMID: 19838917; PubMed Central PMCID: PMC3212936.

2008

  • Chari ST, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M, Petersen GM. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology. 2008 Jan;134(1):95-101.
  • Jiao L, Hassan MM, Bondy ML, Wolff RA, Evans DB, Abbruzzese JL, Li D. XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer. Am J Gastroenterol. 2008 Feb;103(2):360-7.
  • McWilliams RR, Bamlet WR, Cunningham JM, Goode EL, de Andrade M, Boardman LA, Petersen GM. Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res. 2008 Jun 15;68(12):4928-35.

2007

  • Abe T, Fukushima N, Brune K, Boehm C, Sato N, Matsubayashi H, Canto M, Petersen GM, Hruban RH, Goggins M. Genome-wide allelotypes of familial pancreatic adenocarcinomas and familial and sporadic intraductal papillary mucinous neoplasms. Clin Cancer Res. 2007 Oct 15;13(20):6019-25.
  • Chan JM, Wang F, Holly EA. Whole grains and risk of pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area, California. Am J Epidemiol. 2007 Nov 15;166(10):1174-85.
  • Crous-Bou M, Porta M, López T, Jariod M, Malats N, Alguacil J, Morales E, Fernandez E, Corominas JM, Carrato A, Guarner L, Real FX; PANKRAS II Study Group. Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer. Pancreas. 2007 Aug;35(2):135-41.
  • Eppel A, Cotterchio M, Gallinger S. Allergies are associated with reduced pancreas cancer risk: A population-based case-control study in Ontario, Canada. Int J Cancer. 2007 Nov 15;121(10):2241-5.
  • Hassan MM, Abbruzzese JL, Bondy ML, Wolff RA, Vauthey JN, Pisters PW, Evans DB, Khan R, Lenzi R, Jiao L, Li D. Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study. Cancer. 2007 Jun 15;109(12):2547-56.
  • Lo AC, Soliman AS, El-Ghawalby N, Abdel-Wahab M, Fathy O, Khaled HM, Omar S, Hamilton SR, Greenson JK, Abbruzzese JL. Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk. Pancreas. 2007 Aug;35(2):120-9.
  • Wang L, Bamlet WR, de Andrade M, Boardman LA, Cunningham JM, Thibodeau SN, Petersen GM. Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1455-9.

2006

  • Berrington de González A, Spencer EA, Bueno-de-Mesquita HB, Roddam A, Stolzenberg-Solomon R, Halkjaer J, Tjønneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Boeing H, Pischon T, Linseisen J, Rohrmann S, Trichopoulou A, Benetou V, Papadimitriou A, Pala V, Palli D, Panico S, Tumino R, Vineis P, Boshuizen HC, Ocke MC, Peeters PH, Lund E, Gonzalez CA, Larrañaga N, Martinez-Garcia C, Mendez M, Navarro C, Quirós JR, Tormo MJ, Hallmans G, Ye W, Bingham SA, Khaw KT, Allen N, Key TJ, Jenab M, Norat T, Ferrari P, Riboli E. Anthropometry, physical activity, and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):879-85.
  • Wang F, Gupta S, Holly EA. Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1458-63.
  • Larsson SC, Håkanson N, Permert J, Wolk A. Meat, fish, poultry and egg consumption in relation to risk of pancreatic cancer: a prospective study. Int J Cancer. 2006 Jun 1;118(11):2866-70.

2005

  • Anderson KE, Kadlubar FF, Kulldorff M, Harnack L, Gross M, Lang NP, Barber C, Rothman N, Sinha R. Dietary intake of heterocyclic amines and benzo(a)pyrene: associations with pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2261-5.
  • Boffetta P, Aagnes B, Weiderpass E, Andersen A. Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int J Cancer. 2005 May 10;114(6):992-5.
  • Chan JM, Wang F, Holly EA. Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area. Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2093-7.
  • Duell EJ, Holly EA. Reproductive and menstrual risk factors for pancreatic cancer: a population-based study of San Francisco Bay Area women. Am J Epidemiol. 2005 Apr 15;161(8):741-7.
  • Eberle CA, Bracci PM, Holly EA. Anthropometric factors and pancreatic cancer in a population-based case-control study in the San Francisco Bay area. Cancer Causes Control. 2005 Dec;16(10):1235-44.
  • Li D, Ahmed M, Li Y, Jiao L, Chou TH, Wolff RA, Lenzi R, Evans DB, Bondy ML, Pisters PW, Abbruzzese JL, Hassan MM. 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1470-6.
  • Nkondjock A, Krewski D, Johnson KC, Ghadirian P; Canadian Cancer Registries Epidemiology Research Group. Dietary patterns and risk of pancreatic cancer. Int J Cancer. 2005 May 1;114(5):817-23.
  • Nkondjock A, Ghadirian P, Johnson KC, Krewski D; Canadian Cancer Registries Epidemiology Research Group. Dietary intake of lycopene is associated with reduced pancreatic cancer risk.. J Nutr. 2005 Mar;135(3):592-7.
  • Do MT, Birkett NJ, Johnson KC, Krewski D, Villeneuve P; Canadian Cancer Registries Epidemiology Research Group. Chlorination disinfection by-products and pancreatic cancer risk. Environ Health Perspect. 2005 Apr;113(4):418-24. Erratum in: Environ Health Perspect. 2005 Aug;113(8):A511.

2004

  • Alguacil J, Silverman DT. Smokeless and other noncigarette tobacco use and pancreatic cancer: a case-control study based on direct interviews. Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):55-8.
  • Villeneuve PJ, Johnson KC, Mao Y, Hanley AJ; Canadian Cancer Registries Research Group. Environmental tobacco smoke and the risk of pancreatic cancer: findings from a Canadian population-based case-control study. Can J Public Health. 2004 Jan-Feb;95(1):32-7.

2003

  • Bonelli L, Aste H, Bovo P, Cavallini G, Felder M, Gusmaroli R, Morandini E, Ravelli P, Briglia R, Lombardo L, De Micheli A, Pugliese V. Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case-control study in northern Italy. Pancreas. 2003 Aug;27(2):143-9.
  • Holly EA, Eberle CA, Bracci PM. Prior history of allergies and pancreatic cancer in the San Francisco Bay area. Am J Epidemiol. 2003 Sep 1;158(5):432-41.

2002

  • Anderson KE, Sinha R, Kulldorff M, Gross M, Lang NP, Barber C, Harnack L, DiMagno E, Bliss R, Kadlubar FF. Meat intake and cooking techniques: associations with pancreatic cancer. Mutat Res. 2002 Sep 30;506-507:225-31.
  • Duell EJ, Holly EA, Bracci PM, Wiencke JK, Kelsey KT. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res. 2002 Aug 15;62(16):4630-6.

2001

  • Boffetta P, Dosemeci M, Gridley G, Bath H, Moradi T, Silverman D. Occupational exposure to diesel engine emissions and risk of cancer in Swedish men and women. Cancer Causes Control. 2001 May;12(4):365-74.
  • Ji BT, Silverman DT, Stewart PA, Blair A, Swanson GM, Baris D, Greenberg RS, Hayes RB, Brown LM, Lillemoe KD, Schoenberg JB, Pottern LM, Schwartz AG, Hoover RN. Occupational exposure to pesticides and pancreatic cancer. Am J Ind Med. 2001 Jan;39(1):92-9.

2000

  • Alguacil J, Porta M, Benavides FG, Malats N, Kogevinas M, Fernández E, Carrato A, Rifà J, Guarner L. Occupation and pancreatic cancer in Spain: a case-control study based on job titles. PANKRAS II Study Group. Int J Epidemiol. 2000 Dec;29(6):1004-13.
  • Alguacil J, Kauppinen T, Porta M, Partanen T, Malats N, Kogevinas M, Benavides FG, Obiols J, Bernal F, Rifà J, Carrato A. Risk of pancreatic cancer and occupational exposures in Spain. PANKRAS II Study Group. Ann Occup Hyg. 2000 Aug;44(5):391-403.
  • Hoppin JA, Tolbert PE, Holly EA, Brock JW, Korrick SA, Altshul LM, Zhang RH, Bracci PM, Burse VW, Needham LL. Pancreatic cancer and serum organochlorine levels. Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):199-205.

1999

  • Hruban RH, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJ, Falatko F, Yeo CJ, Kern SE. Familial pancreatic cancer. Ann Oncol. 1999;10 Suppl 4:69-73.

1998

  • Silverman DT, Swanson CA, Gridley G, Wacholder S, Greenberg RS, Brown LM, Hayes RB, Swanson GM, Schoenberg JB, Pottern LM, Schwartz AG, Fraumeni JF Jr, Hoover RN. Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst. 1998 Nov 18;90(22):1710-9.

1996

  • Silverman DT, Schiffman M, Devesa S. Diagnostic certainty in pancreatic cancer. J Clin Epidemiol. 1996 May;49(5):601-3.

1995

  • Silverman DT, Brown LM, Hoover RN, Schiffman M, Lillemoe KD, Schoenberg JB, Swanson GM, Hayes RB, Greenberg RS, Benichou J, et al. Alcohol and pancreatic cancer in blacks and whites in the United States. Cancer Res. 1995 Nov 1;55(21):4899-905.

1994

  • Silverman DT, Dunn JA, Hoover RN, Schiffman M, Lillemoe KD, Schoenberg JB, Brown LM, Greenberg RS, Hayes RB, Swanson GM, et al. Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst. 1994 Oct 19;86(20):1510-6.

1993

  • Zheng W, McLaughlin JK, Gridley G, Bjelke E, Schuman LM, Silverman DT, Wacholder S, Co-Chien HT, Blot WJ, Fraumeni JF Jr. A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States). Cancer Causes Control. 1993 Sep;4(5):477-82.

1991

  • Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D, Persson I. Cancer risk in patients with diabetes mellitus. Cancer Causes Control. 1991 Sep;2(5):307-14.

1988

  • Devesa SS, Silverman DT. Protective effect of oestrogen in pancreatic cancer. Lancet. 1988 Oct 15;2(8616):905-6.

© Copyright 2007-2013 - Pancreatic Cancer Case-Control Consortium